Pilot randomised controlled trial of a patient navigation intervention to enhance engagement in the PrEP continuum among young Latino MSM: a protocol paper

Aaron J Blashill, Janna R Gordon, Sarah A Rojas, Christian B Ramers, Chii-Dean Lin, Claudia M Carrizosa, Kelsey A Nogg, Kalina M Lamb, Nicholas C Lucido, Isaiah J Jones, David Rivera, Rosa A Cobian Aguilar, John P Brady, Martin Fuentes, Kristen J Wells, Aaron J Blashill, Janna R Gordon, Sarah A Rojas, Christian B Ramers, Chii-Dean Lin, Claudia M Carrizosa, Kelsey A Nogg, Kalina M Lamb, Nicholas C Lucido, Isaiah J Jones, David Rivera, Rosa A Cobian Aguilar, John P Brady, Martin Fuentes, Kristen J Wells

Abstract

Introduction: Men who have sex with men (MSM) are one of the most at-risk group for contracting HIV in the USA. However, the HIV epidemic impacts some groups of MSM disproportionately. Latino MSM comprise 25.1% of new HIV infections among MSM between the ages of 13 and 29 years. The daily medication tenofovir/emtricitabine was approved by the Food and Drug Administration for pre-exposure prophylaxis (PrEP) in 2012 and has demonstrated strong efficacy in reducing HIV acquisition.

Methods and analysis: Through extensive formative research, this study uses a pilot randomised controlled trial design and will examine the feasibility and acceptability of a patient navigation intervention designed to address multiple barriers to improve engagement in the PrEP continuum among 60 Latino MSM between the ages of 18 and 29 years. The patient navigation intervention will be compared with usual care plus written information to evaluate the feasibility and acceptability of the intervention and study methods and the intervention's potential in improving PrEP continuum behaviours. The results will be reviewed for preparation for a future full-scale efficacy trial.

Ethics and dissemination: This study was approved by the institutional review board at San Diego State University and is registered at ClinicalTrials.gov. The intervention development process, plan and the results of this study will be shared through peer-reviewed journal publications, conference presentations and healthcare system and community presentations.

Registration details: Registered under the National Institutes of Health's ClinicalTrials.gov (NCT04048382) on 7 August 2019 and approved by the San Diego State University (HS-2017-0187) institutional review board. This study began on 5 August 2019 and is estimated to continue through 31 March 2021. The clinical trial is in the pre-results stage.

Keywords: HIV & AIDS; preventive medicine; protocols & guidelines; public health; quality in health care.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Potential patient navigation intervention processes at each level of the PrEP continuum (PrEP continuum varies between the top box, ‘identified as candidate for PrEP’, and the bottom box, ’PrEP adherence and persistence’). PrEP, pre-exposure prophylaxis.

References

    1. Healthy People . Topics and objectives: HIV 2016, 2020. Available: [Accessed 05 Jan 2017].
    1. . National HIV/AIDS strategy: overview. Available: [Accessed 05 Jan 2017].
    1. Centers for Disease Control and Prevention . HIV and Gay and Bisexual Men, 2018. Available: [Accessed 02 Feb 2019].
    1. Smith DK, Van Handel M, Wolitski RJ, et al. . Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. MMWR Morb Mortal Wkly Rep 2015;64:1291–5. 10.15585/mmwr.mm6446a4
    1. Centers for Disease Control and Prevention . Diagnoses of HIV infection in the United States and dependent areas, 2014. In: HIV surveillance report. 26, 2015: 1–123.
    1. Anderson PL, Glidden DV, Liu A, et al. . Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012;4:151ra25-51ra25. 10.1126/scitranslmed.3004006
    1. Pulsipher CA MJ, Plant A, Curtis P. Addressing PreP dispartities among young gay and bisexual men in California: California HIV/AIDS research program. 41, 2016.
    1. Golub SA, Gamarel KE, Rendina HJ, et al. . From efficacy to effectiveness: facilitators and barriers to PreP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS 2013;27:248–54. 10.1089/apc.2012.0419
    1. Bauermeister JA, Meanley S, Pingel E, et al. . Prep awareness and perceived barriers among single young men who have sex with men. Curr HIV Res 2013;11:520–7. 10.2174/1570162X12666140129100411
    1. Ayala G, Makofane K, Santos G-M, et al. . Access to basic HIV-related services and PreP acceptability among men who have sex with men worldwide: barriers, facilitators, and implications for combination prevention. J Sex Transm Dis 2013;2013:1–11. 10.1155/2013/953123
    1. Kimball D, Rivera D, Gonzales M, et al. . Medical Mistrust and the PreP cascade among Latino sexual minority men. AIDS Behav 2020;24:3456–61. 10.1007/s10461-020-02916-z
    1. Rivera DB, Brady JP, Blashill AJ. Traditional Machismo, Caballerismo, and the pre-exposure prophylaxis (PreP) cascade among a sample of Latino sexual minority men. J Sex Res 2021;58:21–8. 10.1080/00224499.2020.1743961
    1. 7th International conference on HIV treatment and prevention adherence . The spectrum of engagement in HIV prevention: proposal for a PreP cascade. Miami Beach, Florida: 7th International conference on HIV treatment and prevention adherence, 2012.
    1. Braschi CD, Sly JR, Singh S, et al. . Increasing colonoscopy screening for Latino Americans through a patient navigation model: a randomized clinical trial. J Immigr Minor Health 2014;16:934–40. 10.1007/s10903-013-9848-y
    1. Enard KR, Nevarez L, Hernandez M, et al. . Patient navigation to increase colorectal cancer screening among Latino Medicare enrollees: a randomized controlled trial. Cancer Causes Control 2015;26:1351–9. 10.1007/s10552-015-0620-6
    1. Wilson FA, Villarreal R, Stimpson JP, et al. . Cost-Effectiveness analysis of a colonoscopy screening navigator program designed for Hispanic men. J Cancer Educ 2015;30:260–7. 10.1007/s13187-014-0718-7
    1. Family Health Centers of San Diego . Welcome to gay men’s health service, 2015. Available: [Accessed 11 Feb 2019].
    1. Whitehead AL, Julious SA, Cooper CL, et al. . Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016;25:1057–73. 10.1177/0962280215588241
    1. United States Census Bureau . QuickFacts: San Diego County, California, 2019. Available: [Accessed 13 Apr 2019].
    1. Newport F, Gates G. San Francisco Metro area ranks highest in LGBT percentage, 2015. Available: [Accessed 01 Jun 2016].
    1. US Public Health Service . Preexposure prophylaxis for the prevention of HIV infection in the United States-2014: a clinical practice guideline, 2014. Available: [Accessed 05 Jan 2017].
    1. Medsharing, Inc . Randomizer for Clinical Trial [program. Fontenay Sous Bois, France: Medsharing, Inc, 2016.
    1. Bartholomew LK, Parcel GS, Kok G. Planning health promotion programs: an intervention mapping approach. Third ed. San Francisco, California: Jossey-Bass, 2011.
    1. Calhoun EA, Whitley EM, Esparza A, et al. . A national patient navigator training program. Health Promot Pract 2010;11:205–15. 10.1177/1524839908323521
    1. Attkisson CC, Greenfield TK. The UCSF Client Satisfaction Scales: I. The Client Satisfaction Questionnaire-8. : Maruish ME, . The use of psychological testing for treatment planning and outcomes assessment. 3rd ed. Mahwah, New Jersey: Lawrence Erlbaum Associates, 2004.
    1. Jean-Pierre P, Fiscella K, Winters PC, et al. . Psychometric development and reliability analysis of a patient satisfaction with interpersonal relationship with navigator measure: a multi-site patient navigation research program study. Psychooncology 2012;21:986–92. 10.1002/pon.2002
    1. McKenna SP, Doward LC. The translation and cultural adaptation of patient-reported outcome measures. Value Health 2005;8:89–91. 10.1111/j.1524-4733.2005.08203.x
    1. Swaine-Verdier A, Doward LC, Hagell P, et al. . Adapting quality of life instruments. Value Health 2004;7 Suppl 1:S27–30. 10.1111/j.1524-4733.2004.7s107.x
    1. Epstein J, Santo RM, Guillemin F. A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol 2015;68:435–41. 10.1016/j.jclinepi.2014.11.021
    1. AARDEX . MEMS, 2010. Available: [Accessed 15 Sep 2010].
    1. Katz ML, Young GS, Reiter PL, et al. . Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. Womens Health Issues 2014;24:e155–62. 10.1016/j.whi.2013.10.010
    1. Bowen DJ, Kreuter M, Spring B, et al. . How we design feasibility studies. Am J Prev Med 2009;36:452–7. 10.1016/j.amepre.2009.02.002
    1. Sekhon M, Cartwright M, Francis JJ. Acceptability of health care interventions: a theoretical framework and proposed research agenda. Wiley Online Library, 2018.
    1. QSR International . NViVo 10 For Windows [program, 2014.
    1. Knodel J. The design and analysis of focus group studies: a practical approach. successful focus groups: advancing the state of the art. London: Sage Publications, 1993: 35–50.
    1. SAS Institute . SAS software version 9.4 [program. Cary, NC, 2013.
    1. Grant RM, Lama JR, Anderson PL, et al. . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587–99. 10.1056/NEJMoa1011205
    1. Mustanski B, Ryan DT, Hayford C, et al. . Geographic and individual associations with PreP stigma: results from the radar cohort of diverse young men who have sex with men and transgender women. AIDS Behav 2018;22:3044–56. 10.1007/s10461-018-2159-5
    1. Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas 2007;15:203–19. 10.1891/106137407783095757
    1. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1–24. 10.1080/08870449908407311
    1. Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. 2nd. Sydney: Psychology Foundation of Australia, 1995.
    1. Hahn EA, DeWalt DA, Bode RK, et al. . New English and Spanish social health measures will facilitate evaluating health determinants. Health Psychol 2014;33:490–9. 10.1037/hea0000055

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する